Johnson Financial Group Inc (Wisconsin)’s Sonoma Pharmaceuticals SNOA Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio SNOA Stock Details SNOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1	Closed	–	–	731
2022 Q1	$0	Hold	1	–	–	﹤0.01%	802
2021 Q4	$0	Hold	1	–	–	﹤0.01%	829
2021 Q3	$0	Hold	1	–	–	﹤0.01%	790
2021 Q2	$0	Hold	1	–	–	﹤0.01%	798
2021 Q1	$0	Buy	+1	New	+$162	﹤0.01%	687
2016 Q2	–	Sell	-2	Closed	-$1K	–	790
2016 Q1	$1K	Hold	2	–	–	﹤0.01%	733
2015 Q4	$2K	Hold	2	–	–	﹤0.01%	740
2015 Q3	$2K	Hold	2	–	–	﹤0.01%	778
2015 Q2	$2K	Hold	2	–	–	﹤0.01%	843
2015 Q1	$1K	Hold	2	–	–	﹤0.01%	822
2014 Q4	$2K	Buy	+2	New	+$3.12K	﹤0.01%	757

Other funds holding SNOA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HFS

HBC Financial Services Seattle, Washington $163M AUM 14.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s SNOA Position: Q2 2022 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Sonoma Pharmaceuticals (SNOA) in Q2 2022, closing a stake of 1 share.

Johnson Financial Group Inc (Wisconsin) first reported a position in SNOA in Q4 2014 and held it in 11 quarters. The position peaked at $2K in Q4 2015. 17 funds tracked by Wall St. Rank hold SNOA as of Q2 2022.

Johnson Financial Group Inc (Wisconsin) reported no remaining Sonoma Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
Johnson Financial Group Inc (Wisconsin) sold 1 Sonoma Pharmaceuticals share in Q2 2022.
Johnson Financial Group Inc (Wisconsin) first reported a position in Sonoma Pharmaceuticals in Q4 2014 and held it in 11 quarters.
Johnson Financial Group Inc (Wisconsin)'s Sonoma Pharmaceuticals position peaked at $2K in Q4 2015.
17 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q2 2022.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2022, filed 15 Aug 2022.